HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Toubeau, M. Articles by Brunotte, F. Search for Related Content PubMed PubMed Citation Articles by Toubeau, M. Articles by Brunotte, F.

Predictive Value for Disease Progression of Serum Thyroglobulin Levels Measured in the Postoperative Period and After ¹³¹I Ablation Therapy in Patients with Differentiated Thyroid Cancer

¹ Department of Nuclear Medicine, Centre Georges François Leclerc, Dijon, France
² Department of Medical Statistics, Centre Georges François Leclerc, Dijon, France
³ Department of Radiotherapy, Centre Georges François Leclerc, Dijon, France
⁴ Department of Endocrinology, University Hospital, Dijon, France

View larger version (14K): [in a new window]   FIGURE 1. Progression-free survival curves according to initial lymph node status. There was no significant difference (P = 0.18) between pN0 and pNx patients. A significant difference was found between pN0 and pN1 (P = 0.0001) and between pNx and pN1 (P < 0.0001).

View larger version (14K): [in a new window]   FIGURE 2. Progression-free survival curves according to Tg1 level measured in postoperative period just before IAT.

View larger version (14K): [in a new window]   FIGURE 3. Progression-free survival curves according to Tg2 level measured 6–12 mo after IAT.